Tao Synergies Inc (TAOX) Stock Price, Quote & News

Company Profile

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.

Industry: Capital Markets

Sector: Financial Services

Phone: 973 242 0005

Website: taosynergies.com

Address:

1185 Avenue of the Americas, 3rd Floor, New York, United States

EndGame1 Aug. 18 at 4:53 PM

$TAOX "Bittensor Ecosystem Expands with New Infrastructure and Commercial Deployments: Bittensor's ecosystem saw new launches including Hippius for storage and Vidaio's AI video platform, alongside Green Compute adding GPUs. These developments are part of the network's ongoing expansion and utility growth."

0 · Reply

show_me_the_money_Adam Aug. 18 at 4:11 PM

$TAOX My average is at $4.02 I'll look to add more over the next few weeks. Should be a different story heading into September/ October.

0 · Reply

EndGame1 Aug. 17 at 2:34 PM

$TAOX Soon... "xTAO Completes Validator Upgrade for Bittensor Protocol: xTAO has successfully completed a validator upgrade. This upgrade was implemented to provide support for a new Bittensor protocol update, enhancing network functionality." "Bittensor's Ditto Subnet Integrates Engy for Ultracheap Inference: Bittensor's Ditto subnet (SN118) now supports ultracheap inference from Engy (subnet 53). This expands providers powered by Bittensor, allowing builders to earn TAO."

0 · Reply

show_me_the_money_Adam Aug. 13 at 7:48 PM

$TAOX Another week or two and I see this at $4.50ish

0 · Reply

show_me_the_money_Adam Aug. 13 at 6:32 PM

$TAOX Added a little more on this dip.

0 · Reply

show_me_the_money_Adam Aug. 13 at 2:26 PM

$TAOX I don’t mind if we hover at these prices another week or two. Once $GP has it's run, I'll bring more money here.

0 · Reply

bobtheunbuilder Aug. 13 at 12:33 AM

$TAOX garbage company. Just transferring wealth from the many to the few. Just go buy TAO

1 · Reply

EndGame1 Aug. 12 at 6:44 PM

$TAOX Liking the chart for long term break out... https://www.coingecko.com/en/coins/bittensor?chart=type%3Dprice%26mode%3Dline%26timeframe%3Dd90

0 · Reply

EndGame1 Aug. 12 at 5:25 PM

$TAOX $TAO.X Hanging on the $200 mark. "Bittensor Gains as Wintermute Plans $1B AI Investment: Wintermute's announcement of a planned $1 billion investment in AI and high-frequency trading data centers over five years has driven Bittensor's price up 0.67% in 24 hours, with the coin also benefiting from positive sentiment around Nvidia's new AI model approach validating its subnet architecture."

1 · Reply

EndGame1 Aug. 12 at 3:05 PM

$TAOX "Nvidia Validates Bittensor's Decentralized AI Subnet Thesis: Nvidia's new routing/cheaper-model approach validates a market for specialized, permissionless subnets. This aligns with Bittensor's architecture and may boost TAO visibility."

0 · Reply

TAO Synergies appoints Jeffrey as an advisor to the Company

Jul 8, 2026, 9:15 AM EDT - 5 weeks ago

TAO Synergies Appoints Bittensor Investor and Author Mark Jeffrey as Advisor

2026-06-16T13:21:36.000Z - 2 months ago

TAO Synergies to join the Russell Microcap Index

Jun 16, 2026, 9:15 AM EDT - 2 months ago

TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI

Nov 18, 2025, 5:15 PM EST - 9 months ago

Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

BEX CSEX NNEX SNPX

Nov 18, 2025, 9:15 AM EST - 9 months ago

TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

Nov 13, 2025, 6:46 AM EST - 9 months ago

Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys

BEX CSEX NNEX SNPX

2025-11-12T21:22:16.000Z - 9 months ago

TAO Synergies files to sell 22.3M shares of common stock for holders

Nov 11, 2025, 11:26 AM EST - 10 months ago

Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

BEX CSEX NNEX SNPX

2025-11-04T14:20:39.000Z - 10 months ago

TAO Synergies announces initial $750K investment in Bittensor Subnet Funds

Nov 4, 2025, 9:15 AM EST - 10 months ago

TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

2025-10-20T13:20:22.000Z - 10 months ago

TAO Synergies reports total TAO increased to 54,058 tokens

Oct 20, 2025, 9:15 AM EDT - 10 months ago

TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

2025-10-13T21:15:14.000Z - 11 months ago

TAO Synergies announces $11M private placement

Oct 13, 2025, 5:09 PM EDT - 11 months ago

TAO Synergies Announces $11 Million Private Placement

Sep 22, 2025, 9:15 AM EDT - 11 months ago

TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

Sep 8, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event

Aug 26, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy

2025-08-14T20:55:13.000Z - 1 year ago

TAO Synergies files $100M mixed securities shelf

2025-07-17T13:21:08.000Z - 1 year ago

TAO Synergies acquires $10M of Bittensor

2025-07-11T21:05:08.000Z - 1 year ago

TAO Synergies files to sell 5.04M shares of common stock for holders

Jul 1, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today

Jun 26, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy

Jun 24, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Jun 9, 2025, 9:00 AM EDT - 1 year ago

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Dec 20, 2024, 9:15 AM EST - 1 year ago

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Sep 11, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces $5.0 Million Financing

Jul 18, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Jun 26, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

May 7, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery

Apr 24, 2024, 9:15 AM EDT - 2 years ago

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Dec 19, 2023, 9:00 AM EST - 2 years ago

Synaptogenix President Daniel L. Alkon, M.D.

Dec 6, 2023, 9:00 AM EST - 2 years ago

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Nov 2, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology

Sep 26, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease

Sep 7, 2023, 9:00 AM EDT - 3 years ago

Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

Jul 19, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

Jul 13, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience

Mar 7, 2023, 9:00 AM EST - 3 years ago

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

Dec 16, 2022, 9:00 AM EST - 3 years ago

Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

Nov 18, 2022, 9:00 AM EST - 4 years ago

Synaptogenix Announces $15 Million Private Placement with Existing Investors

Oct 19, 2022, 9:00 AM EDT - 4 years ago

Synaptogenix to Present at ThinkEquity Investor Conference on October 26, 2022

Sep 28, 2022, 11:50 AM EDT - 4 years ago

Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

Aug 12, 2022, 9:00 AM EDT - 4 years ago

Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

Jul 26, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

Jul 21, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Corporate Update Conference Call

Jul 20, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data

May 17, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at the Cell Symposium

Apr 19, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Completes Patient Enrollment in NIH Sponsored Phase 2b Alzheimer's Disease Trial

Apr 5, 2022, 9:15 AM EDT - 4 years ago

New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix's Bryostatin for Alzheimer's Disease

Mar 29, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit

Mar 22, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum

Mar 15, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present Research Highlighting Potential Broad Applicability for Lead Compound Bryostatin at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

Feb 23, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Feb 1, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients

Sep 10, 2021, 9:00 AM EDT - 5 years ago

Synaptogenix Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 5, 2021, 10:00 AM EDT - 5 years ago

Synaptogenix Signs Memorandum Of Understanding with Nemours A.I. DuPont Hospital to Initiate Trial Using Bryostatin, Under Orphan Drug Status, to Treat Fragile X Syndrome

Jul 26, 2021, 9:15 AM EDT - 5 years ago

Synaptogenix Discloses Positive Results of Further Bryostatin Trial Analyses in Presentation at Alzheimer's Association International Conference 2021

EndGame1 Aug. 18 at 4:53 PM

0 · Reply

show_me_the_money_Adam Aug. 18 at 4:11 PM

$TAOX My average is at $4.02 I'll look to add more over the next few weeks. Should be a different story heading into September/ October.

0 · Reply

EndGame1 Aug. 17 at 2:34 PM

0 · Reply

show_me_the_money_Adam Aug. 13 at 7:48 PM

$TAOX Another week or two and I see this at $4.50ish

0 · Reply

show_me_the_money_Adam Aug. 13 at 6:32 PM

$TAOX Added a little more on this dip.

0 · Reply

show_me_the_money_Adam Aug. 13 at 2:26 PM

$TAOX I don’t mind if we hover at these prices another week or two. Once $GP has it's run, I'll bring more money here.

0 · Reply

bobtheunbuilder Aug. 13 at 12:33 AM

$TAOX garbage company. Just transferring wealth from the many to the few. Just go buy TAO

1 · Reply

EndGame1 Aug. 12 at 6:44 PM

$TAOX Liking the chart for long term break out... https://www.coingecko.com/en/coins/bittensor?chart=type%3Dprice%26mode%3Dline%26timeframe%3Dd90

0 · Reply

EndGame1 Aug. 12 at 5:25 PM

1 · Reply

EndGame1 Aug. 12 at 3:05 PM

0 · Reply

EndGame1 Aug. 11 at 2:33 PM

$TAOX $TAO.X Worth a 47-minute listen on X with @ jaltucher and @ markjeffrey Be sure to listen to the one on X also, with @ Jason and @ const_reborn of @ bittensor $TAO.X

1 · Reply

EndGame1 Aug. 11 at 2:15 PM

$TAOX It's time. Lots of positive $TAO.X podcast and videos over the past week. More than I can remember.

1 · Reply

EndGame1 Aug. 10 at 1:38 PM

$TAOX $TAO.X Finally broke $200. TAO Synergies is way undervalued now. "Bittensor (TAO) Surpasses $202.5 Amid Whale Accumulation and Rising Activity: Bittensor (TAO) has broken above the $202.5 mark. This price movement is supported by observed whale accumulation and an increase in overall market activity."

0 · Reply

Jimmybelanger3 Aug. 8 at 6:11 AM

$TAOX how high do you think we can go?

3 · Reply

dario2580 Aug. 7 at 11:06 PM

$TAOX In July 2026, they brought on Mark Jeffrey a Bittensor-focused investor and early Bitcoin author, as an advisor to help with subnet investing and DeAI strategy.

0 · Reply

show_me_the_money_Adam Aug. 5 at 7:17 PM

$TAOX Added more today

0 · Reply

EndGame1 Aug. 5 at 4:01 PM

$TAOX It's really trying, but can $TAO.X just break $200 /coin and never look back!

0 · Reply